-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-testing-evaluation_research.pdf
January 01, 2009 - 13-MDM347013 30..38
Medical Tests—White Paper Series
Additional Patient Outcomes and Pathways in
Evaluations of Testing
The findings and conclusions in this document are those of the authors, who are responsible for its
contents; the findings and conclusions do not necessarily represent the views…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief1-care-coordination.pdf
April 01, 2021 - Rapid Evidence Product
April 2021
Care Coordination and Care Plans for
Transitions Across Care Settings
Purpose
The purpose of this topic development brief is to explore and scope the evidence on care
coordination and care plans for transitions across care settings (“transitional care interventions”)
i…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2436
Published Online: March 24, 2017
Comparative Effectiveness Review Disposition of Comments Re…
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
March 24, 2017 - Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy
Source: https://www.effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-reports/
?pageaction=displayproduct&productid=2436
Published Online: March 24, 2017
Comparative Effectiveness Review Disposition of Comments Re…
-
effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-32-pharm-non-pharm-ptsd.pdf
May 14, 2019 - TEP Reviewer #3 Background Exec summary-1 Would be good to provide estimated timeline
for completion
-
effectivehealthcare.ahrq.gov/products/primary-healthcare-spending/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-update-appendix-g-tables.xlsx
January 01, 2022 - G-2. RoB Assessment
Table G-2. Risk of bias assessment of prior report studies
Author, Year
Selection Bias:
Randomization Adequate? Selection Bias:
Allocation Concealment Adequate? Selection Bias:
Groups Similar at Baseline?
Selection Bias:
ITT Analysis? Performance Bias:
Care Providers Masked? Performance Bias:
Pa…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/binge-eating-disposition-160504.pdf
December 09, 2015 - Disposition of Comments for CER 160 Binge Eating Disorder
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Management and Outcomes of Binge-Eating Disorder.
Draft review available for public comment from January 22, 2015 to March 4, 2015.
Research Review …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
August 24, 2012 - Comparative Effectiveness Review Disposition of Comments Report
Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&productID=1235
Published Online: August 24, 2012
Comparative Effectiveness Research Review Disposition of Comments Report
Research …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
April 03, 2013 - Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD)
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Psychological Treatments and Pharmacological Treatments for Adults
With Pos…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
June 17, 2014 - Disposition of Comments Report for Technical Brief 15 Transition Care for Children With Special Health Needs
Technical Brief Disposition of Comments Report
Technical Brief Title: Transition Care for Children With Special Health Needs
Draft available for public comment from December 19, 2013 to January 15…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
January 01, 2010 - 1
Comparative Effectiveness Review
Number 57
Methods for Insulin Delivery and Glucose
Monitoring: Comparative Effectiveness
Executive Summary
Background
Diabetes mellitus is defined as a group
of metabolic diseases characterized by
hyperglycemia resulting from defects
in insulin secretion from the pancreati…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - Using adjusted rate differences, estimated
2.2 (CI, 1.4 to 3.0) more CVD events or deaths and 1.2 (CI
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
October 01, 2016 - Evidence Report No. 222, Data Linkage Strategies To Advance Youth Suicide Prevention
Evidence Report/Technology Assessment
Number 222
Data Linkage
Strategies To
Advance Youth
Suicide Prevention
Evidence-Based
Practice
Evidence Report/Technology Assessment
Number 222
Data Linkage Strategies To Advance Y…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antibiotics-respiratory-infection_disposition-comments.pdf
January 27, 2016 - Disposition of Comments for CER 163 Appropriate Antibiotics
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Improving Antibiotic Prescribing for Uncomplicated Acute
Respiratory Tract Infections
Draft review available for public comment from February 10, 2015 to Ma…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - fair 9539/NR/8076 History of inflammatory arthritis
other than RA; upper GI surgery or
inflammatory; estimated … Valdecoxib reviews
Eisen
2005
Not reported AEs estimated using Kaplan-Meier time-to-event analysis
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Acute Treatment for Episodic Migraine: Surveillance Report 2
1
Acute Treatments for Episodic Migraine:
Surveillance Report 2
Literature Update Period: September 2, 2021, Through December 30, 2021
Background and Purpose
This report is the second surveillance report for the Agency for Healthcare Research and
…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-1-year-final-report-updated-title_0.pdf
May 01, 2024 - Making Healthcare Safer IV: Summary of Findings, 2023-2024
Making Healthcare Safer IV
Making Healthcare Safer IV: Summary of Findings on
Patient Safety Practices and Ratings by a Technical
Expert Panel, 2023-2024
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Se…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
June 01, 2022 - Acute Treatment for Episodic Migraine: Surveillance Report 2
Acute Treatments for Episodic Migraine:
Surveillance Report 2
Literature Update Period: September 2, 2021, Through December 30, 2021
Background and Purpose
This report is the second surveillance report for the Agency for Healthcare Research and
Quali…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-screening_executive.pdf
February 01, 2012 - 1
Comparative Effectiveness Review
Number 52
Fecal DNA Testing in Screening for Colorectal
Cancer in Average-Risk Adults
Executive Summary
Background
Colorectal cancer (CRC) is the third
most common cancer in both men and
women and is the third leading cause
of cancer deaths in the United States.1
Incidence…